Real-world safety and effectiveness of maintenance niraparib for platinum-sensitive recurrent ovarian cancer: A GEICO retrospective observational study within the Spanish expanded-access programme.

Juan F Cueva,Isabel Palacio,Cristina Churruca,Ana Herrero,Beatriz Pardo,Manuel Constenla,Ana Santaballa,Luis Manso,Purificación Estévez,Constanza Maximiano,Marta Legerén,Gloria Marquina,Ana de Juan,María Quindós,Luisa Sánchez,Arantzazu Barquin,Isaura Fernández,Cristina Martín,Asunción Juárez,Teresa Martín,Yolanda García,Alfonso Yubero, Alejandro Gallego, Alejandro Martínez Bueno,Eva Guerra,Antonio González-Martín

European journal of cancer (Oxford, England : 1990)（2023）

Cited 2|Views49
No score
Abstract
NCT04546373.
More
Translated text
Key words
Elderly,Individualised,Niraparib,PARP inhibitor,Platinum-sensitive,Real-world data,Recurrent ovarian cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined